SEARCH

SEARCH BY CITATION

References

  • Amuron B, Namara G, Birungi J et al. (2009) Mortality and loss to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9, 290.
  • Anglaret X, Dakoury-Dogbo N, Bonard D et al. (2002) Causes and empirical treatment of fever in HIV-infected adult outpatients, Abidjan, Cote d’Ivoire. AIDS 16, 909918.
  • Boehme C, Nabeta P, Hillemann D et al. (2010) Rapid molecular detection of tuberculosis and rifampicin resistance. New England Jounal of Medicine 363, 10051015.
  • Braitstein P, Brinkhof M, Dabis F et al. (2006) The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) Groups. Mortality of HIV-1 infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817824.
  • Etard J, Ndiaye I, Thierry-Mieg M et al. (2006) Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20, 11811189.
  • Fox M, Brennan A, Maskew M, MacPhail P & Sanne I (2010) Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Tropical Medicine and International Health 15, 405413.
  • Gilks C (1998) Acute bacterial infections and HIV disease. British Medical Bulletin 54, 383393.
  • Gilks C, Brindle R, Newnham R et al. (1990) Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 346, 545549.
  • Grant A, Djomand G & De Cock K (1997) Natural history and spectrum of disease in adults with HIV/AIDS in Africa. AIDS 11, S43S54.
  • Ingle S, May M, Uebel K et al. (2010a) Differences in access and patient outcomes across antiretroviral treatment clinics in the Free State province: a prospective cohort study. South African Medical Journal 100, 675681b.
  • Ingle S, May M, Uebel K et al. (2010b) Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. AIDS 24, 27172725.
  • Janoof E, Breima R, Daley C & Hopewell P (1992) Pneumococcal disease during HIV infection. Epidemiologic, clinical and immunological perspectives. Annals of Internal Medicine 117, 314324.
  • Jones N, Huebner R, Khoosal M, Crewe-Brown H & Klugman K (1998) The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population. AIDS 12, 21772184.
  • Larson B, Brennan A, McNamara L et al. (2010) Early loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South Africa. Tropical Medicine and International Health 15, S43S47.
  • Lawn S, Myer L, Orrell C, Bekker L & Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19, 21412148.
  • Lawn S, Harries A, Anglarete X, Myerg L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 18971908.
  • Lucas S, De Cock K, Hounnou A et al. (1994) Contribution of tuberculosis to slim disease in Africa. British Medicial Journal 308, 15311533.
  • NASCOP (2005) Guidelines for Antiretroviral Drug Therapy in Kenya. 3rd edn. Minitsry of Health, Nairobi, Kenya. Available at: http://apps.who.int/medicinedocs/documents/s16742e/s16742e.pdf (Accessed 14 March 2010).
  • Peters RPH, Zijlstra EE, Schijffelen MJ et al. (2004) A prospective study of bloodstream infections as a cause of fever in Malawi: clinical predictors and implications for management. Tropical Medicine and International Health 9, 928934.
  • Scott J, Hall A, Muyodi C et al. (2000) Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 355, 12251230.
  • Van Griensven J, Sopheak T, Aseffa Y, Van Damme W & Lynen L (2010) Attrition of HIV-infected individuals not yet eligible for antiretroviral treatment: do we care? Transations of the Royal Society of Tropical Medicine and Hygiene 104, 690692.
  • WHO Rapid advice. antiretroviral therapy for HIV infection in adults and adolescents. November 30,2009. World Health Organsiation, Geneva, Switzerland. Available at: http://www.who.int/hiv/pub/arv/advice/en/. (Accessed 21 September 2010).
  • Zachariah R, Tayler-Smith K, Massaquoi M & Harries A (2010) Attrition of HIV-infected individuals not yet eligible for antiretroviral therapy. Why should we care? Transations of the Royal Society of Tropical Medicine and Hygiene 104, 690693.